Tina Colombo
- Oncology top 5%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Maurizio D’IncalciMassimo BrogginiMassimo ZucchettiM.G. DonelliSilvio GarattiniJulie M. CherringtonNancy PryerTinya J. Abrams
- Topics
- Cancer Treatment and Pharmacology (18 papers)Cancer therapeutics and mechanisms (13 papers)Chemotherapy-induced cardiotoxicity and mitigation (13 papers)
- Cited by
- OncologyCancer ResearchPharmacology
- Journals
- Cancer ResearchBiochemical and Biophysical Research CommunicationsBritish Journal of Cancer
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Tina Colombo
75 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 110
- Oncology 910
- Molecular Biology 737
- Pulmonary and Respiratory Medicine 295
- Cancer Research 242
- Cardiology and Cardiovascular Medicine 187
Countries citing papers authored by Tina Colombo
This map shows the geographic impact of Tina Colombo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina Colombo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina Colombo more than expected).
Fields of papers citing papers by Tina Colombo
This network shows the impact of papers produced by Tina Colombo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina Colombo. The network helps show where Tina Colombo may publish in the future.
Co-authorship network of co-authors of Tina Colombo
This figure shows the co-authorship network connecting the top 25 collaborators of Tina Colombo. A scholar is included among the top collaborators of Tina Colombo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tina Colombo. Tina Colombo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 51 | |
| 2 | 15 | |
| 3 | 43 | |
| 4 | 35 | |
| 5 | Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer. | 215 |
| 6 | 62 | |
| 7 | 6 | |
| 8 | 87 | |
| 9 | 9 | |
| 10 | 38 | |
| 11 | 8 | |
| 12 | 31 | |
| 13 | 16 | |
| 14 | 3 | |
| 15 | 21 | |
| 16 | 11 | |
| 17 | 5 | |
| 18 | Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice. | 39 |
| 19 | Differential distribution of antitumor agents in primary and secondary tumors. | 35 |
| 20 | Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect. | 14 |
About Tina Colombo
Tina Colombo is a scholar working on Oncology, Hematology and Biophysics, having authored 76 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (18 papers), Cancer therapeutics and mechanisms (13 papers) and Chemotherapy-induced cardiotoxicity and mitigation (13 papers). The work is most often cited by research in Oncology (910 citations), Cancer Research (242 citations) and Pharmacology (133 citations). Tina Colombo has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Maurizio D’Incalci, Massimo Broggini, Massimo Zucchetti, M.G. Donelli, Silvio Garattini, Julie M. Cherrington, Nancy Pryer, Tinya J. Abrams, Enrico Pesenti and Leslie B. Lee. Their work appears in journals such as Cancer Research, Biochemical and Biophysical Research Communications and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.